Page last updated: 2024-10-22

alendronate and Hypopituitarism

alendronate has been researched along with Hypopituitarism in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Hypopituitarism: Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanimoto, K1
Okubo, Y1
Harada, C1
Saito, H1
Sata, A1
Nishikawa, A1
Ohwada, R1
Tsuiki, M1
Yamamoto, M1
Hashimoto, E1
Sato, K1
Takano, K1

Other Studies

1 other study available for alendronate and Hypopituitarism

ArticleYear
Latent hypoparathyroidism in an osteoporotic patient with multiple endocrinopathies and secondary hemochromatosis due to multiple blood transfusions, unmasked by alendronate and glucocorticoid at adrenal crisis.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:6

    Topics: Adrenal Glands; Adult; Alendronate; Bone Density Conservation Agents; Bone Resorption; Calcium; Diab

2008